The agency suggested cutting a dozen quality measures where health plan performance is high and beneficiaries can’t easily ...
The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.
CMS outlines a 2027 Medicare rule proposing major Star Ratings updates, a new behavioral health measure, and streamlined ...
The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...
The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...
The Centers for Medicare & Medicaid Services Nov. 25 issued a proposed rule for policies governing the Medicare Advantage and Part D programs for 2027.
The second round of Inflation Reduction Act negotiation prices, which includes 15 brand-name drugs, will kick into effect in 2027.
Options for Medicare and Medicaid Dual Coverage People who are eligible for both Medicare and Medicaid benefits are referred to as dual eligible. A person may have partial or full dual eligibility.
CMS Gives Most-Favored-Nation Pricing for Drugs a New Platform in Its Pilot “Generous Model” Program
In May 2025, President Trump issued Executive Order No. 14297, titled “Delivering Most-Favored-Nation Prescription Drug ...
The U.S. Centers for Medicare and Medicaid Services (CMS) announced a new program to reduce prescription drug costs for Americans. The Generating Cost Reduction for U.S., known as GENEROUS, aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback